Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRIN TRIAL
NCT06468202Phase 4Recruiting
- Sponsor
- The Ohio State University
- Start
- Oct 2024
- Primary completion
- Jan 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in hypertensive disorders of pregnancy (HDP), sponsored by The Ohio State University. Started Oct 2024; status: recruiting.
02
Drugs
aspirin
03
Conditions
hypertensive disorders of pregnancy (HDP)
Beyond the preview
Go deeper on NCT06468202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06468202.